NLS Pharmaceutics Ltd. ("NLS"), a Swiss clinical-stage biopharmaceutical company focused on central nervous system and neurodegenerative disorders and Kadimastem Ltd. ("Kadimastem"), a clinical-stage ...
Some of the most expensive drugs currently in use are gene therapies to treat specific diseases, and their high cost limits ...
Seven years after the first gene-edited babies were revealed, biotech startup Manhattan Genomics is reviving the idea of ...
Caltech researchers have reintroduced a classic technique to image the formation and growth of individual cells that make up ...
To solve this critical challenge, he founded Nephrogen in 2022, a biotech startup that uses AI and advanced screening to ...
In the 24 years since 9/11, Diane Keating has never given an interview. Why now? “People and families need to know they are still looking,” she told Spectrum News. Nearly a quarter of a century on, ...
Decades of research has viewed DNA as a sequence-based instruction manual ... This decay results in neurodegeneration, cancer, or other diseases of aging.” “The next step is to fully learn the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback